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Acceleration of cancer progression after surgery is frequently
encountered in clinical settings and is reproducible in animal
experimental models (Kodama et al, 1992; Bogden et al, 1997).
Surgical procedures cause tissue injuries resulting in release of
various cytokines, or growth factors, in wound fluid. If residual
cancer cells are present near the resection margin or in the fluid
space, they are directly influenced by mitogenic or motogenic
humoural factors in the wound environment.
Hepatocyte growth factor (HGF) was first identified (Nakamura
et al, 1984) and cloned (Miyazawa et al, 1989; Nakamura et al,
1989) as a potent mitogen for cultured hepatocytes. Recent studies
have shown that the HGF has a number of biological activities; for
example, mitogenic, motogenic, and morphogenic (Zarnegar and
Michalopoulos 1995; Matsumoto and Nakamura 1997). HGF is
produced by stromal or mesenchymal cells (Noji et al, 1990;
Matsumoto et al, 1992; Sonnenberg et al, 1993), and targets a wide
variety of cells (Weidner et al, 1990; Zarnegar and Michalopoulos,
1995). It enhances the invasion and metastasis of cancer cells 
that express an HGF receptor, a c-met proto-oncogene product
(Giordano et al, 1993; Jeffers et al, 1996). HGF is a stromal-
derived polypeptide that affects invasion of carcinoma cells via
tumour–stromal interactions (Matsumoto et al, 1996; Nakamura 
et al, 1997). We have recently shown that HGF stimulates matrix
metalloproteinase (MMP)-1 and MMP-2 production in human
colon carcinoma cells (Uchiyama et al, 1996). On the other hand,
HGF plays a role in enhancing regeneration of organs such as
liver, kidney and lung. The expression of HGF is rapidly induced
following injuries in these organs (Zarnegar and Michalopoulos,
1995; Matsumoto and Nakamura, 1997). These findings suggest
that HGF may be secreted in the wound microenvironment after
some surgical procedures, and that the HGF may play a role in
progression of residual cancer cells.
Kimura et al (1996) have reported secretion of HGF in the
wound fluid in hepatic resection surgery. However, little is known
about HGF secretion in the pleural fluid after lung surgery. This is
an important point to consider, because the lung is thought to be
one of the key organs that produces HGF (Yanagita et al, 1992),
and an association of HGF with progression of non-small-cell lung
cancer has recently been reported (Siegfried et al, 1997). In the
study presented here, we measured HGF concentration in pleural
fluid after lung surgery, and examined whether HGF in the pleural
fluid can stimulate matrix invasion by lung carcinoma cells in
vitro.
MATERIALS AND METHODS
Collection of samples
Pleural fluid was obtained from thoracic drain tubes from seven
cases of pulmonary resection surgery for primary or metastatic
lung cancer at the Department of Surgery I, Kyushu University
Faculty of Medicine. The present study was carried out with the
approval of the ethical committee organized by senior staffs in the
Department of Surgery I. Informed consent for collecting serum
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patient before surgery. The serum samples were collected simulta-
neously from peripheral blood. The supernantants of the samples
were collected by centrifugation at 2200 rpm for 20 min and were
stored at –80°C until assay.
Enzyme-linked immunosorbent assay
HGF concentrations in the samples were measured with the aid 
of an HGF enzyme-linked immunosorbent assay (ELISA) kit
(Institute of Immunology, Tokyo, Japan) following the manufac-
turer’s instructions. Fivefold diluted pleural fluids and twofold
diluted sera were used for the measurement of HGF concentration.
The detection limit of this assay is 0.10 ng ml–1.
Cell line
A human lung adenocarcinoma cell line A549 was purchased from
the Japanese Cancer Research Resources Bank. The cells were
maintained in RPMI-1640 medium (Nissui, Tokyo, Japan) supple-
mented with 10% fetal bovine serum (Gibco-BRL, NY, USA) and
antibiotics.
Human recombinant HGF and HGF-neutralizing
antibody
Human recombinant HGF was purified from the culture medium
of Chinese hamster ovary cells transfected with an expression
plasmid containing human HGF cDNA (Nakamura et al, 1989).
Neutralizing polyclonal antibody against HGF was prepared from
rabbits immunized with the human recombinant HGF (Matsumoto
et al, 1996; Nakamura et al, 1997).
In vitro invasion assay
The invasive response of carcinoma cells to the pleural fluid was
assessed with the aid of blind-well chemotaxis Boyden chambers
as described by Sieuwerts et al (1997) with some modifications.
Figure 1 shows the schema of this assay system. Both upper and
lower sides of polycarbonate filters (8-mm pore size, 13-mm in
diameter; Nucleopore, CA, USA) were coated with Matrigel
(Collaborative Research Inc., Bedford, MA, USA). The lower side
of the filter was first coated with Matrigel to promote attachment
of the cells. Thirty-microlitre drops of Matrigel (2 mg ml–1 in
serum-free medium) were placed in plastic dishes. Filters were
placed on top of the drop of Matrigel. After 1 h incubation at 37°C,
the upper side of the filter was coated with 35 ml of Matrigel and
placed in an incubator for 1 h to allow the Matrigel to form an
even gel layer on the filter. The lower compartment of the Boyden
chambers was filled with either 225 ml of medium alone, sera
obtained from normal subjects, or diluted pleural fluid samples.
The coated filters were placed in the Boyden chambers. A549 lung
carcinoma cells (4 ´ 104 cells per well) suspended in the growth
medium were added to the upper compartment and incubated for
24 h at 37°C in atmosphere of 5% carbon dioxide in air. At the end
of the incubation period the non-invasive cells, which remained on
the top of the filter, were removed with a cotton swab and the inva-
sive cells, which were attached to the underside of the filter, were
stained with Diff-Quick staining solutions (Baxter, McGaw Park,
IL, USA). The cells attached to the lower surface were counted in
a total of five microscopic fields (´200), and each assay was done
in triplicate. The number of the invading cells per five fields was
used as a measure of invasion-stimulatory activity of the samples.
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Figure 1 Schema of the in vitro invasion assay system. The assay was
performed as described in Materials and Methods
Table 1 Clinical characteristics of patients from whom pleural fluids were collected after pulmonary resection surgery
Case Age Sex Diagnosis Stage Operation Postoperative HGF level (ng/ml) in pleural fluid
complication after surgery (PODa)
1. 70 F Lung cancer IIB Right upper lobectomy None 15.0 (Day 1), 9.2 (Day 2), 6.2 (Day 3)
2. 47 M Lung cancer IIB Left upper lobectomy None 12.4 (Day 1)
3. 70 M Lung cancer I Left lower lobectomy None 9.5 (Day 1), 9.6 (Day 3), 6.0 (Day 4)
4. 69 M Lung cancer I Right upper lobectomy None 5.2 (Day 1), 4.2 (Day 2), 11.2 (Day 3),
23.0 (Day 5), 11.5 (Day 6), 7.0 (Day 7)
5. 60 F Colon cancer IV Right lower lobectomy None 18.0 (Day 2)
Lung metastasis
6. 70 M Colon cancer IV 1) Right partial resection None 15.5 (Day 2), 7.5 (Day 4)
Lung metastasis 2) Left partal resection None 10.0 (Day 1)
3) Left lower lobectomy Air leak 11.0 (Day 3), 8.5 (Day 6)
7. 67 M Rectal cancer IV 1) Right partial resection None 8.0 (Day 1)
Lung metastasis 2) Left partial resection None 7.2 (Day 1), 9.2 (Day 2), 10.4 (Day 3)
aPOD (post-operative day) at sample collection.Statistical analyses
The Kruskal-Wallis ANOVA test was used for assessing the
significance of differences in HGF concentration between the
pleural fluid and the serum samples. Student’s t-test was used for
analysis of unpaired samples. Correlation was assessed using the
Spearman’s rank correlation test. Differences at the probability
value less than 0.05 were considered significant.
RESULTS
Pleural fluid samples were obtained from ten pulmonary resections
from seven patients with primary or metastatic lung cancer. Table
1 shows patients’ characteristics. None of them had pleural effu-
sion before surgery. Patients 6 and 7 were operated on more than
once. No cases had post-operative complications related to infec-
tion. In patient 4, both serum and pleural HGF levels were
measured for 7 days. The HGF concentration in each pleural fluid
sample is also shown in Table 1.
In the patients 1, 3, 4 and 7 (Table 1), the HGF concentrations in
the pleural fluids were measured on 3–6 postoperative day points.
Figure 2 shows a time course of pleural and serum HGF levels
after lung surgery in patient 4. The HGF levels in the pleural fluids
reached a maximum value on post-operative day (POD) 5 after
surgery and decreased slowly afterwards. The pleural HGF levels
were higher than the serum HGF levels during the 7 days after
operation. The post-operative day point with maximum HGF level
varied from POD 1 to POD 5. The similar time course of pleural
HGF level after lung surgery was observed in our preliminary
experiments (data not shown).
The HGF concentrations in 23 samples of the pleural fluid
ranged from 6.0 to 23.0 ng ml–1 with an average of 10.2 ± 4.3 (s.d.)
ng ml–1 (Figure 3). Because we had no control over HGF level in
the pleural fluid, the data were compared with the serum HGF
levels in normal subjects and in the patients before and after the
operation. The post-operative serum samples were collected
simultaneously with the pleural fluid samples. The average serum
HGF level in healthy volunteers was 0.36 ± 0.13 ng ml–1 (n = 50).
The patients’ serum HGF concentrations before and after opera-
tion were 0.61 ± 0.33 and 1.01 ± 0.72 ng ml–1 respectively (n = 9).
HGF secretion after lung surgery 723
British Journal of Cancer (1999) 81(4), 721–726 © 1999 Cancer Research Campaign
25
20
15
10
5
0
0123567
Days after operation
H
G
F
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
n
g
 
m
l
–
1
)
Figure 2 Time course of HGF concentration in serum (open square) and
pleural fluid (open circle) after operation in case 4. The HGF levels in the
pleural fluids reached a maximum value on POD 5 after surgery and
decreased slowly afterwards
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Figure 3 HGF concentrations in the sera of normal subjects and patients
before and after operation, and in the pleural fluid after lung surgery.
*Significant difference by Kruskal-Wallis ANOVA test (P < 0.0001)
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Figure 4 Invasion of lung carcinoma cell line A549 across reconstituted
basement membrane (Matrigel) in the presence of the serially-diluted pleural
fluid after lung surgery. The pleural fluid sample was obtained on POD 6
after the third operation in case 6. The results of triplicate experiments are
shown. The value was compared with that in the presence of medium alone.
**P <0.01, *P <0.05
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Figure 5 The matrix invasion by lung carcinoma cells in the presence of the
culture medium alone (n = 6), twofold-diluted sera from normal subjects
(n = 4), and twofold-diluted pleural fluid after surgery (n = 7). The pleural fluid
samples used in this experiment were as follows: POD 1 in patient 1, POD 1
in patient 2, POD 1 and 4 in patient 3, POD 3 in patient 4, POD 3 after the
third operation in patient 6, and POD 1 after the second operation in patient
7. The invasion was significantly higher in the presence of pleural fluid
compared with that in the presence of culture medium and normal sera by
Kruskal–Wallis ANOVA test. *P < 0.01The HGF level in the pleural fluid was shown to be significantly
higher than the serum HGF levels by the Kruskal–Wallis ANOVA
test (P < 0.0001).
The HGF is known to stimulate invasion of carcinoma cells. To
examine whether the pleural fluid can stimulate carcinoma cell
invasion, serial dilutions of a pleural fluid sample obtained on
POD 6 after the third operation in case 6 were tested for the effect
on matrix invasion by a lung carcinoma cell line. The A549 line
was positive for c-Met/HGF receptors as determined by reverse
transcription polymerase chain reaction (RT-PCR) and Western
blot analysis (data not shown). As shown in Figure 4, carcinoma
cell invasion in the presence of medium alone and in the undiluted
pleural fluid was 44.3 ± 5.2 and 306.3 ± 41.8 cells per 5 fields
respectively. The difference between the two average values was
significant (P < 0.01). Serial dilution (two-, three-, and fourfold)
of the pleural fluid samples decreased the invasive response,
suggesting the presence of invasion-stimulatory activity in the
pleural fluid. Then we tested further seven pleural fluid samples
from five cases for the effects on carcinoma cell invasion and
compared them with the effects of culture medium and serum from
four normal subjects (Figure 5). The matrix invasion by lung carci-
noma cells was significantly (P < 0.01) increased in the presence
of the pleural fluid (556.4 ± 236.9 cells per 5 fields) compared
with that in the presence of culture medium (159.5 ± 76.9 cells per
5 fields) and normal sera (117.7 ± 94.4 cells per 5 fields).
To examine whether the HGF in the pleural fluid contributes to
invasion-stimulatory activity, HGF-neutralizing antibody against
HGF (2.5 mg ml–1) was added to the lower compartment of the
chamber with pleural fluid samples obtained from three cases (one
obtained on POD 3 in case 4 [A], one on POD 1 in case 3 [B], and
one on POD 3 of the third operation in case 6 [C]). Each sample
was diluted, and the HGF concentration in the lower compartment
was adjusted to 3.75, 4.75, or 5.50 ng ml–1 in the pleural fluid A, B,
or C respectively. The A549 lung carcinoma cells invaded the
Matrigel in response to 5 ng ml–1 of the recombinant human HGF.
To confirm the activity of the HGF-neutralizing antibody, the
antibody (2.5 mg ml–1) was added in the lower compartment with
5 ng ml–1 recombinant HGF. As shown in Figure 6, the antibody
completely blocked the invasion stimulated by the HGF. The
HGF-neutralizing antibody almost completely blocked the carci-
noma cell invasion in response to the pleural fluids A and B, and
significantly blocked the invasion in response to the pleural fluid
C (Figure 6).
The relationship between HGF level and invasion-stimulatory
activity (number of invading carcinoma cells) among the seven
pleural fluids and four normal sera was analysed. These samples
were the same as those used in the experiments shown in Figure 5.
A positive correlation was found (P = 0.0073).
DISCUSSION
We found that high concentrations of HGF are secreted in the
pleural fluid after lung surgery, that pleural fluid can stimulate
carcinoma cell invasion in vitro, and that HGF mediates such
activity at least in part. Although such activity was found in vitro,
these results suggest that the local HGF induced by lung surgery
may contribute to invasive progression of residual carcinoma
cells.
Kenworthy et al (1992) and Eagles et al (1996) have previously
reported the presence of HGF in malignant pleural effusions. They
showed the presence of HGF by both ELISA and biological assay
for cell scattering activity, and suggested that HGF may contribute
to metastatic spread in the pleura. We have shown the presence
and activity of the HGF in pleural fluid after lung surgery.
Stimulation of chemoinvasion by carcinoma cells is a unique
characteristics of HGF (Giordano et al, 1993), and matrix invasion
by cancer cells is an important step in metastatic behaviour. The
median HGF levels in pleural effusion fluids from lung cancer
patients demonstrated by Eagles et al (1996) was 0.49 ng ml–1. On
the other hand, the HGF levels in the pleural fluids after lung
surgery in the current study ranged from 6.0 to 23.0 ng ml–1 with
an average of 10.1 ng ml–1. The difference of the HGF concentra-
tion in the pleural fluid between these pre- and post-operative
studies is remarkable. Together with the data of time course of
HGF concentration in the pleural fluid after surgery, it is suggested
that the HGF concentration in the pleural fluid increased following
lung surgery. The level of HGF in pleural fluid after surgery was
high, average being 10.1 ng ml–1. A number of in vitro experi-
ments have shown that concentrations of HGF above 1 ng ml–1
stimulate motility and invasion of carcinoma cells expressing the
HGF receptors (Uchiyama et al, 1996; Nakamura et al, 1997). The
HGF level in pleural fluid after lung surgery cannot be negligible
for it to have an effect on invasion of residual carcinoma cells.
The identification of the HGF in the post-operative pleural fluid
prompted us to investigate the invasive response of lung carci-
noma cells to the pleural fluid. As expected, the pleural fluid
stimulated matrix invasion by the lung carcinoma cells in vitro.
This was evidenced by the findings that the invasive response in
the presence of the pleural fluid was reduced by serial dilution of
the fluid, and that sera from normal subjects had significantly
lower activity to stimulate carcinoma cell invasion. The in vitro
invasion assay in this study has been used to examine the invasion
of carcinoma cells across the reconstituted basement membrane in
response to chemoattractants present in the pleural fluid. A
number of cytokines, or growth factors, are thought to be present
in the pleural fluid. Among them, the HGF is known to be a unique
growth factor that can stimulate carcinoma cell invasion. In our
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Figure 6 Inhibition of invasion-stimulatory activity in the pleural fluid by
HGF-neutralizing antibody. Antibody (2.5 mg ml–1) was added to the lower
compartment of the chamber with either the recombinant HGF (5 ng ml–1) or
diluted pleural fluids obtained from three different cases (one obtained on
POD3 in case 4 (A), one on POD1 in case 3 (B), and one on POD3 after the
third operation in case 6 (C)). *P < 0.01experiments, HGF-neutralizing antibody inhibited carcinoma cell
invasion in response to the pleural fluid. Positive correlation was
also found between HGF level and invasion-stimulatory activity in
the pleural fluid. Although other cytokines may also be respon-
sible for the enhanced invasion of the carcinoma cells, the HGF is
thought to be one of the key invasion-stimulatory factors in the
microenvironments of lung surgery.
The actual mechanism of HGF secretion into the pleural fluid is
uncertain. One of the possible sources of the HGF is lung fibro-
blasts (Weidner et al, 1990). It has been shown that the HGF is
produced by fibroblasts stimulated with inflammatory cytokines
(Matsumoto et al, 1992, 1996; Nakamura et al, 1997). Serum HGF
levels are elevated in patients who underwent hepatectomy
(Tomiya et al, 1992; Kimura et al, 1996), patients with systemic
inflammatory response syndrome (Sakon et al, 1996) and patients
with acute pancreatitis (Ueda et al, 1996). These reports suggest
that secretion of HGF is closely related to the occurrence of
inflammation. Cancer surgery, including organ resection or lymph
node dissection, causes extensive damage to stromal tissue. A
series of inflammatory reactions enabling tissue repair after lung
surgery may play a role in the secretion of HGF. The other possible
sources of the HGF in the lung are endothelial cells in lung
parenchyma and alveolar macrophages (Yanagita et al, 1992).
Since expression of HGF increases following lung injury and HGF
enhances lung regeneration (Yanagita et al, 1993; Ohmichi et al,
1996), the increase of HGF in pleural fluid may possibly reflect
physiological response to enhance the tissue repair process.
Post-operative cancer invasion and metastasis are critical clin-
ical problems in the surgical treatment of cancer (Kodama et al,
1992; Nomoto et al, 1996). It has been shown in an animal model
that the seeding of blood-borne metastases to the lung was signifi-
cantly enhanced by surgical wounding of normal tissues (Bogden
et al, 1997). Case 1 in our series had a sulcus tumour in the right
apex of the lung. Pathological examination of the resected spec-
imen showed that residual carcinoma cells were present in the
surgical margin of the pleura. A follow-up computerized tomog-
raphy examination showed the residual carcinoma invading the
right brachial nerve plexus and thoracic vertebrae only 3 months
after surgery. The expression of c-Met/HGF receptor mRNA and
protein in the resected carcinoma tissue was identified by RT-PCR
and Western blotting analysis. In this case, it is highly probable
that the invasive growth of residual carcinoma cells was enhanced
by HGF and invasion-stimulatory activity in the pleural fluid.
Although further studies are needed to verify the actual roles of the
HGF in clinical cancer invasion and metastasis, surgical oncolo-
gists should be well aware of the fact that lung surgery may
provide a suitable microenvironment for invasion by residual
carcinoma cells in some cases.
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